Minoryx receives approval from Spanish Agency to initiate phase 2 study in Friedreich’s Ataxia
Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases
CarThera obtains ANSM approval to launch its Phase I-II clinical trial for the SonoCloud-9 device in the treatment of recurrent glioblastoma
Metafora biosystems receives reimbursement for test to help diagnose De Vivo disease
GamaMabs Pharma receives Orphan Drug Designation from the US FDA for lead compound GM102
Sebia announces FDA clearance for its Hydrashift 2/4 daratumumab assay
BioAxial granted US patent covering ‘black fluorophore’ technology
Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer
